Astrazeneca Plc ADR (AZN)

May 9, 2025, 7:00 AM EDT - 2 days ago

IMFINZI® (durvalumab) regimen demonstrated statistically significant and clinically meaningful improvement in disease-free survival for high-risk non-muscle-invasive bladder cancer in POTOMAC Phase III trial

May 2, 2025, 2:20 AM EDT - 9 days ago

AstraZeneca's Breztri meets main goals of late-stage asthma trials

Apr 29, 2025, 12:08 PM EDT - 12 days ago

AstraZeneca has built resilient supply chains in U.S., China: CEO

Apr 29, 2025, 12:06 PM EDT - 12 days ago

Pharma firms maastraz

GSK NVO NVS

Apr 29, 2025, 11:46 AM EDT - 12 days ago

AstraZeneca PLC (AZN) Q1 2025 Earnings Conference Call Transcript

Apr 29, 2025, 11:35 AM EDT - 12 days ago

AstraZeneca CEO talks tariffs, first quarter earnings

Apr 29, 2025, 10:18 AM EDT - 12 days ago

AstraZeneca Q1 Earnings Rise, But China Drug Allegations May Lead To $8 Million Penalty

Apr 29, 2025, 5:16 AM EDT - 12 days ago

AstraZeneca to keep 2025 forecast if US pharmaceutical tariffs in line with other sectors

Apr 29, 2025, 4:10 AM EDT - 12 days ago

AstraZeneca Sales, Earnings Rise; Warns of Mounting Legal Challenges in China

Apr 29, 2025, 2:10 AM EDT - 12 days ago

AstraZeneca says may face further import tax fine from China

Apr 29, 2025, 2:00 AM EDT - 12 days ago

AstraZeneca's Q1 2025 Financial Results

Apr 28, 2025, 12:00 PM EDT - 13 days ago

SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR

SOPH

Apr 23, 2025, 8:00 AM EDT - 18 days ago

Tempus Signs Expanded Strategic Agreements with AstraZeneca and Pathos to Develop the Largest Multimodal Foundation Model in Oncology

TEM

Apr 23, 2025, 7:28 AM EDT - 18 days ago

AstraZeneca CEO says Europe must protect its health sovereignty, is falling behind on pharma investments

Apr 22, 2025, 4:10 PM EDT - 19 days ago

AstraZeneca rejoins leading U.S. drug lobby group after two-year absence

Apr 21, 2025, 9:00 AM EDT - 20 days ago

LLY, NVO and AMGN Forecast – Pharma Stocks to Open Mixed

ABBV AMGN BMY GSK JNJ LLY MRK

Apr 20, 2025, 9:15 AM EDT - 21 days ago

Selling America, Buying Europe - My Picks

ASML NVO

Apr 15, 2025, 2:33 PM EDT - 26 days ago

European pharma companies issue demands to stay in EU ahead of expected US tariffs

LLY PFE

Apr 14, 2025, 2:03 PM EDT - 27 days ago

Trump Says Pharmaceutical Tariffs Coming in Near Future

ABBV AMGN BMY GSK IBB JNJ LLY

Apr 14, 2025, 12:26 PM EDT - 27 days ago

Trump says US pharma tariffs coming in not-too-distant future

ABBV AMGN BMY GSK JNJ LLY MRK

Apr 11, 2025, 10:30 AM EDT - 4 weeks ago

Trump's pharmaceutical tariffs could raise costs for patients, worsen drug shortages

ABBV AMGN BMY GSK IBB JNJ LLY

Apr 10, 2025, 4:45 AM EDT - 4 weeks ago

Autos, pharma, luxury and more: The global sectors soaring after Trump's tariffs walkback

ABBV AMGN BMY GSK JNJ LLY MRK

Apr 9, 2025, 6:32 PM EDT - 4 weeks ago

BMO's Siegerman talks the impact of tariffs on pharmaceutical stocks

ABBV AMGN BMY GSK JNJ LLY MRK

Apr 9, 2025, 3:59 PM EDT - 4 weeks ago

Trump's Tariffs Circle Pharma Industry: Who It Affects And How It May Play Out

ABBV AMGN BMY GSK JNJ LLY MRK

Apr 9, 2025, 2:27 PM EDT - 4 weeks ago

Explainer: Prescription drugs become a target in Trump's trade war

ABBV AMGN BMY GSK IBB JNJ LLY

Apr 9, 2025, 1:06 PM EDT - 4 weeks ago

Healthy Returns: Trump says major pharmaceutical tariffs coming ‘very shortly'

ABBV AMGN BMY GSK IBB JNJ LLY

Apr 9, 2025, 11:53 AM EDT - 4 weeks ago

Pharma Stocks Slide Further After Trump Reiterates Tariff Threats on Drugs

ABBV AMGN BMY GSK JNJ LLY MRK

Apr 9, 2025, 11:51 AM EDT - 4 weeks ago

Pharmaceutical stocks fall as Trump doubles down on tariffs threat

LLY ABBV AMGN BMY GSK JNJ MRK

Apr 9, 2025, 9:50 AM EDT - 4 weeks ago

Global pharma shares plunge as Trump doubles down on tariff threat

ABBV AMGN GSK LLY MRK NVS PFE

Apr 8, 2025, 11:32 PM EDT - 4 weeks ago

Trump teases targeted tariffs on overseas drug manufacturers

GSK IHE NVS PJP SNY XPH

Apr 5, 2025, 2:21 AM EDT - 5 weeks ago

AstraZeneca's Innovation Ecosystem: From Blockbusters To The Next Generation Of Therapy

Apr 3, 2025, 6:25 AM EDT - 5 weeks ago

Pharma tariff relief likely short-lived with sector-specific duties on the horizon

NVO NVS

Apr 2, 2025, 11:53 PM EDT - 5 weeks ago

Pharma stocks survive market rout on tariff exemption, but uncertainty continues

GSK NVO

Apr 1, 2025, 1:47 PM EDT - 5 weeks ago

Healthy Returns: AstraZeneca cholesterol pill shows promise as race with Merck heats up

Mar 31, 2025, 2:30 PM EDT - 5 weeks ago

Pharma tariffs the 'number one question' on investors' minds, Barclays says

GSK NVO NVS

Mar 27, 2025, 3:20 PM EDT - 6 weeks ago

Japan Approves BridgeBio Pharma-AstraZeneca Partnered Rare Heart Disease Drug

BBIO

Mar 26, 2025, 9:00 AM EDT - 6 weeks ago

Lunit to Present AI Study on EGFR Mutation Prediction in NSCLC at AACR 2025 in Collaboration with AstraZeneca

Mar 21, 2025, 12:30 PM EDT - 7 weeks ago

AstraZeneca CEO on its $2.5 billion investment in Beijing hub

Mar 21, 2025, 9:25 AM EDT - 7 weeks ago

AstraZeneca to Invest $2.5 Billion in China Amid Probes

Mar 21, 2025, 9:21 AM EDT - 7 weeks ago

Watch CNBC's full interview with AstraZeneca CEO Pascal Soriot

Mar 21, 2025, 8:55 AM EDT - 7 weeks ago

Watch CNBC's full interview with Pascal Soriot, AstraZeneca CEO

Mar 21, 2025, 7:21 AM EDT - 7 weeks ago

Harbour BioMed Enters into Global Strategic Collaboration with AstraZeneca to Discover and Develop Next-Generation Therapeutic Antibodies

Mar 21, 2025, 7:10 AM EDT - 7 weeks ago

British pharma giant AstraZeneca to invest $2.5 billion in new China hub

Mar 21, 2025, 7:03 AM EDT - 7 weeks ago

AstraZeneca investing $2.5 bln in China as drugmaker seeks to recover from scandals

Mar 19, 2025, 8:00 AM EDT - 7 weeks ago

Mindpeak to deploy and evaluate AI-Powered Digital Pathology Risk Assessment Tools for Breast Cancer in collaboration with AstraZeneca

Mar 17, 2025, 8:04 AM EDT - 7 weeks ago

IgniteData launches cutting edge data integration platform for clinical trials at Cambridge University Hospitals

Mar 17, 2025, 5:45 AM EDT - 7 weeks ago

AstraZeneca pays up to $1bn for biotech firm ‘that could transform cell therapy'

Mar 17, 2025, 3:47 AM EDT - 7 weeks ago

AstraZeneca Buys EsoBiotec for Up to $1 Billion

Mar 17, 2025, 3:07 AM EDT - 7 weeks ago

AstraZeneca to buy Esobiotec for upto $1 billion

Mar 17, 2025, 3:00 AM EDT - 7 weeks ago

EsoBiotec to Be Acquired by AstraZeneca to Advance Cell Therapy Ambition